• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Clinical Network Services appoints Francis to BioDesk

Clinical Network Services appoints Francis to BioDesk

March 4, 2013
CenterWatch Staff

Clinical Network Services (CNS), an Australian-based CRO offering integrated development services in phase I and II trials, has appointed ex-Therapeutic Goods Administration (TGA) toxicologist Dr. Douglas Francis senior regulatory toxicologist for the company’s BioDesk product development planning and regulatory affairs service.

He will provide advice and assistance to international and Australian/New Zealand biotechnology companies in toxicology, pharmacology and drug optimization to support conduct of clinical trials and drug registration in key global markets.

Francis is a U.K./European registered toxicologist and a member of the U.S. Society of Toxicology, the American College of Toxicology, the British Toxicology Society and the Roundtable of Toxicology Consultants.

Most recently, he offered regulatory toxicology services to small and medium pharmaceutical and biotech clients in Australia, Europe and the U.S. through his own consultancy, DF Pre-clinical Services. Previously, he was vice president of drug development for Australian biotech Phylogica, and drug development manager at Pharmaxis.  

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • MachineLearning-360x240.png

    Industry Using AI/ML to Improve Data, Quality and Trial Management, Survey Says

  • VirtualTraining-360x240.png

    Virtual Training Evolves into More In-Depth Learning, Improved Communications

  • SurveywBlueBackground-360x240.png

    Mid-Study Updates Delay Trials At Least a Month, CSDD Report Finds

  • Real-TimeData-360x240.png

    Real-Time Data Helped Sponsors Respond to Sites’ Needs During the Pandemic

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing